The following post is from Federal Agency Weekly. It tracks federal grants policy issuances, rulemakings, guidance development and OIG reports and publications. The primary focus of Federal Agency Weekly is agency-wide grants management issues related to extramural research grants from NIH, NSF, NASA, and DOD, though broader coverage of NIH is provided with the inclusion of NIH program activities.
January 6-January 10, 2020
Discover Grants Management Webinars from Thompson Grants
See upcoming schedule ›
National Institutes of Health
- Need help determining if your research involves human subjects? by NIH Staff
- New “All About Grants” Podcast on Certificates of Confidentiality by Lyndi Lahl
- Celebrating 20 Years of ClinicalTrials.gov and Looking to the Future by Rebecca Williams
- January 8, 2020 NIAID Funding News
- Important Reminders for Fellowship and Career Development Applicants
- Dr. Collins Appears on C-SPAN’s Newsmakers Series
- NIH & You: Join Us at the 2020 NIH Regional Seminars in Baltimore & Nashville
- How NIH Can Support Your Career Path by NIH Staff
- Jan. 23-24 Meeting of the National Science Advisory Board for Biosecurity (NSABB) Hosted by NIH
- 1/8/20 FR: Voluntary Self-Disclosure of Violations of the Export Administration Regulations
- Changes to Funding Opportunities
- NOT-AA-19-034: Notice of NIAAA Participation in PA-18-935 “Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional)”
- NOT-DA-20-029: Notice of NIDA Participation in PAR-19-343, “Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 – Independent Clinical Trial Not Allowed)”
- NOT-DE-20-004: Notice of NIDCR Participation in PAR-19-373 “Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed)”
- NOT-DE-20-005: Notice of NIDCR Participation in PAR-19-384 “Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required)”
- NOT-HL-19-474: Notice of Change in Expiration Date of PAR-17-338 “Continuation of Existing Grant Based Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01-Clinical Trials Not Allowed)”
- NOT-NS-20-034: Addition of SBIR Direct-to-Phase II Program to NINDS RFA-NS-18-012, “Translational Neural Devices (U44 Clinical Trial Required)”
- Notices of Intent to Publish
- NOT-NS-20-032: Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
- NOT-NS-20-033: Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
- Notices of Special Interest
- NOT-AR-20-012: HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions
- NOT-CA-20-021: Notice of Special Interest (NOSI): De-implementation of Ineffective or Low-value Clinical Practices along the Cancer Care Continuum
- NOT-DA-20-007: Notice of Special Interest (NOSI): Preclinical and Clinical Studies of the Interactions of Opioids and Stimulants
- NOT-DA-20-012: Notice of Special Interest (NOSI): Biomarkers and Biotypes of Drug Addiction
- NOT-NS-20-029: Notice of Special Interest: Administrative Supplements for Existing NIH Countermeasures Against Chemical Threats (CounterACT) Program Research Grants and Cooperative Agreement Awards
- NOT-NS-20-030: Notice of Special Interest: Administrative Supplements to Promote and Expand into the Research and Development of Medical Countermeasures Against Chemical Threats
- NOT-NS-20-031: Notice of Special Interest: Countermeasures Against Chemical Threats (CounterACT) U54 Centers of Excellence Will Only Support Targeted Chemical Threats of Interest
Other HHS Agencies and Offices
National Science Foundation
- U.S. R&D Increased by $32 Billion in 2017, to $548 Billion; Estimate for 2018 Indicates a Further Rise to $580 Billion
- National Patterns of R&D Resources: 2017–18 Data Update
- Research.gov: Major Research Instrumentation Program (MRI) Instrument Acquisition or Development proposers: See important guidance for proposals in response to Program Solicitation 18-513
- Research.gov: Training-based Workforce Development for Advanced Cyberinfrastructure (CyberTraining) proposers: See important guidance for proposals in response to Program Solicitation 19-524.
- Research.gov Unavailable on Saturday, Jan. 11 from 12:01 AM to 8:00 AM for Scheduled Maintenance
- FastLane Unavailable from 12:01 AM ET to 8:00 AM ET on Saturday, Jan. 11 for Scheduled Maintenance
NASA
- [none posted]
Department of Defense
- Air Force Research Lab forms materials-focused Center of Excellence with Carnegie Mellon
- Army Selects 20 Small Businesses, Research Partners for Tech Development
Office of Management and Budget
- [none posted]
Grants.gov
Miscellaneous Agencies and Offices
- SAM.gov Will Be Down for Scheduled Maintenance Saturday, 01/11/2020 from 8:00 AM to 1:00 PM
- Audit of the Office of Justice Programs Office for Victims of Crime Award to Pennsylvania State University, State College, Pennsylvania, Audit Report 20-021
- U.S. Department of Energy Selects Brookhaven National Laboratory to Host Major New Nuclear Physics Facility
- Department of Energy Announces $32 Million for Small Business Research and Development Grants
- AI That Reflects American Values (White House)
- NIFA Update – Jan. 8, 2020
Federal Agency Weekly is an email transmitted on Friday afternoons to subscribers to MANAGING FEDERAL GRANTS for Colleges and Universities. It tracks federal grants policy issuances, rulemakings, guidance development and OIG reports and publications. The primary focus of Federal Agency Weekly is agency-wide grants management issues related to extramural research grants from NIH, NSF, NASA, and DOD, though broader coverage of NIH is provided with the inclusion of NIH program activities. In general, the specifics of individual funding opportunities are not covered.
Thompson Grants, Washington, D.C.